EXHIBIT A JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto, and any filing on...Joint Filing Agreement • February 13th, 2003 • Rho Capital Partners Inc • Phonograph records & prerecorded audio tapes & disks
Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto, and any filing on Schedule 13D relating to the same investment) with respect to the shares of common stock, par value $0.01 per share, of MM Companies, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement.
FORM OF LOCK-UP AGREEMENTUp Agreement • December 10th, 2010 • Rho Capital Partners Inc • Pharmaceutical preparations • New York
The undersigned understands that you, as Representatives of the several Underwriters, propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Anacor Pharmaceuticals, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters named in Schedule 1 to the Underwriting Agreement (the “Underwriters”), of Common Stock of the Company (the “Securities”) pursuant to a Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission (the “Registration Statement”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.
VOTING AGREEMENTVoting Agreement • October 28th, 2008 • Rho Capital Partners Inc • Pharmaceutical preparations • Delaware
This VOTING AGREEMENT (this "Agreement") is entered into as of October 22, 2008, by and among NitroMed, Inc., a Delaware corporation ("Seller"), and HealthCare Ventures, Rho Ventures and Invus Public Equities, L.P. (each a "Stockholder" and collectively, the "Stockholders") and JHP Pharmaceuticals, LLC, a Delaware limited liability company ("Buyer").
EXHIBIT A JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto, and any filing on...Joint Filing Agreement • August 15th, 2000 • Rho Management Co Inc • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto, and any filing on Schedule 13D relating to the same investment) with respect to the shares of common stock, par value $0.001 per share, of 3-Dimensional Pharmaceuticals, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement.
EXHIBIT CRho Capital Partners Inc • June 27th, 2007 • Services-commercial physical & biological research
This Lock-Up Agreement is being delivered to you in connection with the proposed Purchase Agreement (the "Purchase Agreement") to be entered into by Diversa Corporation, a Delaware corporation (the "Company"), and you and the other Initial Purchasers named in Schedule A to the Purchase Agreement, with respect to the offering (the "Offering") without registration under the Securities Act of 1933, as amended (the "Act"), in reliance on Rule 144A under the Act, of Convertible Senior Notes (the "Notes") of the Company. Capitalized terms used herein without definition shall have the respective meanings ascribed to them in the Purchase Agreement.
NitroMed, Inc. STOCKHOLDER AGREEMENTStockholder Agreement • November 24th, 2008 • Rho Capital Partners Inc • Pharmaceutical preparations • Delaware
THIS STOCKHOLDER AGREEMENT (this “Agreement”), dated as of November , 2008, is by and among NitroMed, Inc., a Delaware corporation (“Public Company”) (only with respect to Section 2(b) and Section 11 (and any provisions relating thereto)), Archemix Corp., a Delaware corporation (“Merger Partner”), and the undersigned stockholder (“Stockholder”) of Public Company.
ARCHEMIX CORP. STOCKHOLDER AGREEMENTArchemix Corp. Stockholder Agreement • November 24th, 2008 • Rho Capital Partners Inc • Pharmaceutical preparations • Delaware
THIS STOCKHOLDER AGREEMENT (this “Agreement”), dated as of November 18, 2008, is by and among NitroMed, Inc., a Delaware corporation (“Public Company”), Archemix Corp., a Delaware corporation (“Merger Partner”) (only with respect to Section 2(b) and Section 7 hereof), and the undersigned stockholder (“Stockholder”) of Merger Partner.
EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby consent to the joint filing by any of them of a Statement on Schedule 13D and any amendments thereto, whether heretofore or hereafter filed, relating to the securities of Diversa Corporation, and...Joint Filing Agreement • March 19th, 2007 • Rho Capital Partners Inc • Services-commercial physical & biological research
The undersigned hereby consent to the joint filing by any of them of a Statement on Schedule 13D and any amendments thereto, whether heretofore or hereafter filed, relating to the securities of Diversa Corporation, and affirm that this Schedule 13D is being filed on behalf of each of the undersigned.
Exhibit D to Statement on Schedule 13D re: Verenium Corporation Lock-Up Agreement, dated October 5, 2009 October 5, 2009 LAZARD CAPITAL MARKETS LLC 30 Rockefeller Plaza New York, New York 10020 Re: Verenium Corporation Offering of Units Dear Sirs: In...Rho Capital Partners Inc • October 23rd, 2009 • Industrial organic chemicals
In order to induce Lazard Capital Markets LLC ("Lazard") to enter in to a certain placement agent agreement with Verenium Corporation, a Delaware corporation (the "Company"), with respect to the public offering (the "Offering") of Units consisting of the Company's Common Stock, par value $0.001 per share ("Common Stock") and warrants to purchase the Common Stock, the undersigned hereby agrees that for a period (the "Lock-up Period") of ninety (90) days following the date of the final prospectus filed by the Company with the Securities and Exchange Commission in connection with the Offering, the undersigned will not, without the prior written consent of Lazard, directly or indirectly, (i) offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose of, any shares of Common Stock or securities convertible into or exercisable or exchangeable for Common Stock (including, without limitation, shares of Common Stock or any such securities which may be deemed to be beneficiall
LOCK-UP AGREEMENT (Diversa Stockholders) THIS LOCK-UP AGREEMENT dated as of February 12, 2007 (this "Agreement") is entered into by and between the undersigned stockholder ("Stockholder") and DIVERSA CORPORATION, a Delaware corporation ("Parent")....Lock-Up Agreement • March 19th, 2007 • Rho Capital Partners Inc • Services-commercial physical & biological research • Delaware
EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby consent to the joint filing by any of them of a Statement on Schedule 13D and any amendments thereto, whether heretofore or hereafter filed, relating to the securities of Verenium Corporation,...Joint Filing Agreement • June 27th, 2007 • Rho Capital Partners Inc • Services-commercial physical & biological research
The undersigned hereby consent to the joint filing by any of them of a Statement on Schedule 13D and any amendments thereto, whether heretofore or hereafter filed, relating to the securities of Verenium Corporation, and affirm that this Schedule 13D is being filed on behalf of each of the undersigned.
Exhibit A to Amendment No. 3 to Schedule 13D for Tercica, Inc. LOCK-UP LETTER AGREEMENT LEHMAN BROTHERS INC. 745 Seventh Avenue New York, New York 10019 Ladies and Gentlemen: The undersigned understands that you (the "Underwriter") propose to enter...Rho Capital Partners Inc • January 27th, 2006 • Pharmaceutical preparations
The undersigned understands that you (the "Underwriter") propose to enter into an Underwriting Agreement (the "Underwriting Agreement") providing for the purchase by the Underwriter of shares (the "Stock") of Common Stock, par value $0.001 per share (the "Common Stock"), of Tercica, Inc., a Delaware corporation (the "Company"), and that the Underwriter proposes to reoffer the Stock to the public (the "Offering").
EXHIBIT B LETTER AGREEMENTLetter Agreement • January 20th, 2004 • Rho Capital Partners Inc • Pharmaceutical preparations
This LOAN MODIFICATION AGREEMENT is entered into on November 28, 2003 by and between 1. A Trust under Indenture dated March 5, 1985, known as the U.S. Trust, d/b/a "ABC Investments" and "DEF Investments" (the "US Trust"), c/o Rho Capital Partners,...Loan Modification Agreement • December 5th, 2003 • Rho Capital Partners Inc • Pharmaceutical preparations
VOTING AGREEMENT THIS VOTING AGREEMENT (this Agreement), is dated as of July 18, 2006, by and between the undersigned stockholder (the Stockholder) of Tercica, Inc., a Delaware corporation (the Company), Ipsen, S.A., a French societe anonyme (Ipsen)...Voting Agreement • July 24th, 2006 • Rho Capital Partners Inc • Pharmaceutical preparations • Delaware
VOTING AGREEMENT (Diversa Stockholders) THIS VOTING AGREEMENT (this "Agreement") is entered into as of February 12, 2007, by and between CELUNOL CORP., a Delaware corporation (the "Company"), and the Major Stockholders of DIVERSA CORPORATION, a...Voting Agreement • March 19th, 2007 • Rho Capital Partners Inc • Services-commercial physical & biological research • Delaware
EXHIBIT A JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto, and any filing on...Joint Filing Agreement • February 13th, 2007 • Rho Capital Partners Inc • Services-business services, nec
Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto, and any filing on Schedule 13D relating to the same investment) with respect to the shares of common stock, par value $0.001 per share, of Auto Data Network, Inc.,and further agree that this Joint Filing Agreement be included as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement.
July 18, 2006 Rho Capital Partners Carnegie Hall Tower 152 West 57th Street 23rd FLoor New York, New York 10019 Re: Ladies and Gentlemen: In connection with the entering into of that certain Stock Purchase and Master Transaction Agreement (the...Rho Capital Partners Inc • July 24th, 2006 • Pharmaceutical preparations
EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby consent to the joint filing by any of them of a Statement on Schedule 13D and any amendments thereto, whether heretofore or hereafter filed, relating to the securities of NitroMed, Inc., and...Joint Filing Agreement • January 20th, 2004 • Rho Capital Partners Inc • Pharmaceutical preparations
The undersigned hereby consent to the joint filing by any of them of a Statement on Schedule 13D and any amendments thereto, whether heretofore or hereafter filed, relating to the securities of NitroMed, Inc., and affirm that this Schedule 13D is being filed on behalf of each of the undersigned.
EXHIBIT A LETTER AGREEMENTLetter Agreement • April 1st, 2004 • Rho Capital Partners Inc • Pharmaceutical preparations
EXHIBIT CLoan Modification Agreement • January 20th, 2004 • Rho Capital Partners Inc • Pharmaceutical preparations
EXHIBIT B LOCK-UP AGREEMENT (Diversa Stockholders) THIS LOCK-UP AGREEMENT dated as of February 12, 2007 (this "Agreement") is entered into by and between the undersigned stockholder ("Stockholder") and DIVERSA CORPORATION, a Delaware corporation...Lock-Up Agreement • June 27th, 2007 • Rho Capital Partners Inc • Services-commercial physical & biological research • Delaware
SENOMYX Public Offering of Common StockRho Capital Partners Inc • July 6th, 2004 • Services-commercial physical & biological research
EXHIBIT A JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto, and any filing on...Joint Filing Agreement • June 22nd, 2007 • Rho Capital Partners Inc • Electromedical & electrotherapeutic apparatus
Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto, and any filing on Schedule 13D relating to the same investment) with respect to the shares of common stock, par value $0.01 per share, of Cyberonics, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement.
EXHIBIT A JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto, and any filing on...Joint Filing Agreement • June 13th, 2005 • Rho Capital Partners Inc • Engines & turbines
Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto, and any filing on Schedule 13D relating to the same investment) with respect to the shares of common stock, par value $0.01 per share, of Capstone Turbine Corporation, and further agree that this Joint Filing Agreement be included as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement.
NITROMED, INC. OPTION CANCELLATION AGREEMENT This OPTION CANCELLATION AGREEMENT (this "Agreement") is entered into as of this ___day of November, 2008, between NitroMed, Inc., a Delaware corporation (the "Company"), and the undersigned holder (the...Option Cancellation Agreement • November 24th, 2008 • Rho Capital Partners Inc • Pharmaceutical preparations • Massachusetts
